← Open Payments lookup

ASSAD MUKHTAR: Open Payments

NPI 1609259001 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$554 in 25 payments from 11 companies in 2025. Trend: 2023 $16 · 2024 $493 · 2025 $554

Food & beverage: $554
CompanyPaymentsAmount
ABBVIE INC.11$270
Otsuka America Pharmaceutical, Inc.2$44
Lundbeck LLC2$41
Neurocrine BioSciences, Inc.2$39
Alkermes, Inc.2$36
Luye Pharma (USA) Ltd.1$28
E.R. Squibb & Sons, L.L.C.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Axsome Therapeutics, Inc.1$19
Supernus Pharmaceuticals, Inc.1$17

Products named: VRAYLAR, CREON, ABILIFY MAINTENA, REXULTI, INGREZZA, ARISTADA, ERZOFRI EXTENDED-RELEASE, COBENFY.

Industry payments across IN — which companies pay providers there.